Sort   by:  
 Page size 
UnknownFour-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Not available
S-EPMC10408259 | biostudies-literature
UnknownCharacteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity.
Not available
S-EPMC10858862 | biostudies-literature
UnknownGenetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
Not available
S-EPMC8105895 | biostudies-literature
UnknownCD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.
Not available
S-EPMC3703870 | biostudies-literature
UnknownPatient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.
Not available
S-EPMC7843954 | biostudies-literature
UnknownComparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Not available
S-EPMC10167602 | biostudies-literature
UnknownThe mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Not available
S-EPMC4262609 | biostudies-literature
UnknownRich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network.
Not available
S-EPMC4504816 | biostudies-literature
UnknownCortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
Not available
S-EPMC4870393 | biostudies-literature
UnknownCerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Not available
S-EPMC4119225 | biostudies-literature
Sort   by:  
 Page size